Please provide your email address to receive an email when new articles are posted on . Reata Pharmaceuticals announced that Skyclarys is now commercially available for patients older than 16 years ...

Friedreich ataxia (FA) is a rare, hereditary neurodegenerative disease that causes difficulties with coordination and balance and reduces lifespan. The disease affects approximately 1 in 50,000 people ...

AJMC ®: What is your background in treating Friedreich ataxia (FA) in clinical practice and in clinical trials? KUO: I am the director of Columbia University’s ataxia center and have extensive ...

Dr. Claudio M. de Gusmao: A 69-year-old man was evaluated in the neurology clinic of this hospital because of progressively worsening ataxia. The patient had been well until 9 years before this ...

Supported by phase 3 trial data showing significant SARA score improvements, levacetylleucine is on track to potentially become the first approved therapy for A-T.

An innovative backpack, incorporating aerospace technology, shows promise as a balance aid for patients with the movement disorder ataxia. Research conducted by Radboud university medical center, in ...

Difficulty balancing or an inability to do so can be caused by any number of factors. Head injuries, migraines, alcohol use, ear infections and medications can all affect your musculoskeletal system ...

A specialist nurse to support patients with the neurological condition ataxia has started work in the South West. It is a rare disorder that mainly affects balance and coordination. Charity Ataxia UK ...

Ataxia is the loss of muscle control in your arms and legs. Ataxia may cause you to lose your balance and walk with an unsteady gait. You may feel dizzy, clumsy, or unable to coordinate and control ...